These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21823054)

  • 1. Stimulation of fat oxidation, but no sustained reduction of hepatic lipids by prolonged pharmacological inhibition of acetyl CoA carboxylase.
    Glien M; Haschke G; Schroeter K; Pfenninger A; Zoller G; Keil S; Müller M; Herling AW; Schmoll D
    Horm Metab Res; 2011 Aug; 43(9):601-6. PubMed ID: 21823054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and synthesis of novel inhibitors of acetyl-CoA carboxylase with in vitro and in vivo efficacy on fat oxidation.
    Keil S; Müller M; Zoller G; Haschke G; Schroeter K; Glien M; Ruf S; Focken I; Herling AW; Schmoll D
    J Med Chem; 2010 Dec; 53(24):8679-87. PubMed ID: 21082864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats.
    Bengtsson C; Blaho S; Saitton DB; Brickmann K; Broddefalk J; Davidsson O; Drmota T; Folmer R; Hallberg K; Hallén S; Hovland R; Isin E; Johannesson P; Kull B; Larsson LO; Löfgren L; Nilsson KE; Noeske T; Oakes N; Plowright AT; Schnecke V; Ståhlberg P; Sörme P; Wan H; Wellner E; Oster L
    Bioorg Med Chem; 2011 May; 19(10):3039-53. PubMed ID: 21515056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.
    Savage DB; Choi CS; Samuel VT; Liu ZX; Zhang D; Wang A; Zhang XM; Cline GW; Yu XX; Geisler JG; Bhanot S; Monia BP; Shulman GI
    J Clin Invest; 2006 Mar; 116(3):817-24. PubMed ID: 16485039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic lipid and carbohydrate metabolism in rats fed a commercial mixture of conjugated linoleic acids (Clarinol G-80).
    Giudetti AM; Beynen AC; Lemmens AG; Gnoni GV; Geelen MJ
    Eur J Nutr; 2005 Feb; 44(1):33-9. PubMed ID: 15309462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
    Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of a Cirsium setidens extract on hepatic fat accumulation in mice fed a high-fat diet via the induction of fatty acid β-oxidation.
    Noh H; Lee H; Kim E; Mu L; Rhee YK; Cho CW; Chung J
    Biosci Biotechnol Biochem; 2013; 77(7):1424-9. PubMed ID: 23832362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model.
    Tamura YO; Sugama J; Iwasaki S; Sasaki M; Yasuno H; Aoyama K; Watanabe M; Erion DM; Yashiro H
    J Pharmacol Exp Ther; 2021 Nov; 379(3):280-289. PubMed ID: 34535562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme A: diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets.
    Yamamoto T; Yamaguchi H; Miki H; Shimada M; Nakada Y; Ogino M; Asano K; Aoki K; Tamura N; Masago M; Kato K
    Eur J Pharmacol; 2010 Aug; 640(1-3):243-9. PubMed ID: 20478303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of preestablished diet-induced fatty liver by oral fatty acid-bile acid conjugates in rodents.
    Leikin-Frenkel A; Goldiner I; Leikin-Gobbi D; Rosenberg R; Bonen H; Litvak A; Bernheim J; Konikoff FM; Gilat T
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1205-13. PubMed ID: 18989145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease.
    Kim MH; Kang KS; Lee YS
    Br J Nutr; 2010 Nov; 104(9):1333-42. PubMed ID: 20687969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soraphen, an inhibitor of the acetyl-CoA carboxylase system, improves peripheral insulin sensitivity in mice fed a high-fat diet.
    Schreurs M; van Dijk TH; Gerding A; Havinga R; Reijngoud DJ; Kuipers F
    Diabetes Obes Metab; 2009 Oct; 11(10):987-91. PubMed ID: 19519866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged feeding of mice with conjugated linoleic acid increases hepatic fatty acid synthesis relative to oxidation.
    Javadi M; Beynen AC; Hovenier R; Lankhorst A; Lemmens AG; Terpstra AH; Geelen MJ
    J Nutr Biochem; 2004 Nov; 15(11):680-7. PubMed ID: 15590272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.
    Abu-Elheiga L; Matzuk MM; Abo-Hashema KA; Wakil SJ
    Science; 2001 Mar; 291(5513):2613-6. PubMed ID: 11283375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats.
    Purushotham A; Shrode GE; Wendel AA; Liu LF; Belury MA
    J Nutr Biochem; 2007 Oct; 18(10):676-84. PubMed ID: 17368879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel coenzyme A:diacylglycerol acyltransferase 1 inhibitor stimulates lipid metabolism in muscle and lowers weight in animal models of obesity.
    Yamamoto T; Yamaguchi H; Miki H; Kitamura S; Nakada Y; Aicher TD; Pratt SA; Kato K
    Eur J Pharmacol; 2011 Jan; 650(2-3):663-72. PubMed ID: 21034741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A herbal extract with acetyl-coenzyme A carboxylase inhibitory activity and its potential for treating metabolic syndrome.
    Chen CH; Chang MY; Lin YS; Lin DG; Chen SW; Chao PM
    Metabolism; 2009 Sep; 58(9):1297-305. PubMed ID: 19500808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise training in ovariectomized rats stimulates estrogenic-like effects on expression of genes involved in lipid accumulation and subclinical inflammation in liver.
    Pighon A; Gutkowska J; Jankowski M; Rabasa-Lhoret R; Lavoie JM
    Metabolism; 2011 May; 60(5):629-39. PubMed ID: 20674948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyl-CoA carboxylase 2 inhibition reduces skeletal muscle bioactive lipid content and attenuates progression of type 2 diabetes in Zucker diabetic fatty rats.
    Takagi H; Ikehara T; Hashimoto K; Tanimoto K; Shimazaki A; Kashiwagi Y; Sakamoto S; Yukioka H
    Eur J Pharmacol; 2021 Nov; 910():174451. PubMed ID: 34454928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
    Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.